The examine — which didn't include tirzepatide as part of the Investigation — was framed to be a counterpoint to another study that identified that GLP-1 agonists improved the risk for pancreatitis.Summary Tirzepatide is a brand new molecule effective at controlling glucose blood stages by combining the dual agonism of Glucose-Dependent Insulin